Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460798
Status:
COMPLETED
Last Update Posted:
2010-11-16
First Post:
2007-04-13
Brief Title:
SUTENT In The First Line Treatment Of Renal Cell Carcinoma
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
A6181115
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc